Stroke prevention in non-valvular atrial fibrillation with rivaroxaban
- PMID: 25337613
Stroke prevention in non-valvular atrial fibrillation with rivaroxaban
Abstract
The new oral anticoagulants are the way of the future when it comes to stroke prevention in atrial fibrillation (AF). The ROCKET-AF trial showed that not only was rivaroxaban non-inferior to warfarin for preventing stroke and systemic embolism, but safer too.
Comment on
-
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.N Engl J Med. 2011 Sep 8;365(10):883-91. doi: 10.1056/NEJMoa1009638. Epub 2011 Aug 10. N Engl J Med. 2011. PMID: 21830957 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical